T2S Group Holding

T2S Group Holding

CCSEMA:T2S
219.80
MAD
+5.20
(+2.42%)
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

Sector
Distribution services
Industry
Medical distributors
Address
Casablanca Morocco
Business
T2S Group Holding is a Morocco-based healthcare technology and medical equipment distribution company specializing in the supply, installation, maintenance, and integration of advanced biomedical systems and turnkey hospital infrastructure across North and Francophone Sub-Saharan Africa. Founded in 1992 and headquartered in Casablanca, Morocco, the company operates through specialized business divisions that provide a comprehensive portfolio of medical technologies: Medical Imaging Systems, comprising magnetic resonance imaging (MRI) platforms, computed tomography (CT) scanners, molecular imaging systems, digital radiography and fluoroscopy units, cardiovascular angiography suites, mammography systems, and diagnostic ultrasound devices; Oncology and Radiation Therapy, featuring advanced linear accelerators, stereotactic radiotherapy platforms, brachytherapy units, radiation treatment planning software, and dosimetry quality assurance systems; Operating Theatre and Critical Care Equipment, including surgical tables, operating lights, surgical integration systems, anesthesia delivery workstations, mechanical ventilators, patient monitoring networks, and electrosurgical units; Ophthalmology and Specialized Surgery, offering optical coherence tomography (OCT) devices, surgical microscopes, phacoemulsification platforms, and ophthalmic laser systems; and In Vitro Diagnostics and Laboratory Solutions, encompassing automated clinical chemistry analyzers, immunoassay instruments, and hematology analyzers. Beyond equipment sales, T2S Group Holding provides extensive life-cycle biomedical engineering services, including 24/7 corrective and preventive maintenance contracts; spare parts logistics; turnkey medical facility design, installation, and architectural planning; and clinical application training for medical specialists and biomedical technicians, serving public hospital centers, private clinics, diagnostic radiology centers, and specialized oncology institutes across Morocco, Senegal, Côte d'Ivoire, and Mauritania. In recent developments, T2S Group Holding has advanced its regional expansion strategy across Francophone West Africa through cross-border commercial subsidiaries and localized service hubs to support modern hospital development projects. The company has also expanded its long-standing strategic distribution partnerships with global medical technology leaders, notably GE HealthCare and Elekta, introducing artificial intelligence-driven diagnostic imaging software and next-generation precision radiotherapy equipment to the African market. Additionally, T2S Group Holding has diversified its service offerings into hospital information systems (HIS), picture archiving and communication systems (PACS), and comprehensive managed equipment services (MES), solidifying its position as an integrated medical technology solutions provider.